Clinical Trials Logo

Common Bile Duct Diseases clinical trials

View clinical trials related to Common Bile Duct Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05755607 Not yet recruiting - Pancreatic Cancer Clinical Trials

A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.

NCT ID: NCT05755594 Not yet recruiting - Pancreatic Cancer Clinical Trials

A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Further studies are needed to investigate the prognosis and perioperative safety of patients undergoing robotic-assisted pancreaticoduodenectomy. In this study, clinical data and prognostic data of patients undergoing this procedure were prospectively collected and analyzed to explore its safety and efficacy.

NCT ID: NCT04503200 Not yet recruiting - Clinical trials for Endoscopic Retrograde Cholangiopancreatography

Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.

Start date: August 15, 2020
Phase: N/A
Study type: Interventional

Difficult cannulation of the common bile duct is encountered in about 10%of ERCP procedures. This frequently happens in the form of repeated unintentional cannulation of the pancreatic duct. Two valid options are available to facilitate cannulation at this point: Double guidewire technique or performing a transpancreatic precut. This is a randomized trial comparing the efficacy and Safety of double guidwire technique versus transpancreatic precut after three unintentional passages of the guidewire into the pancreatic duct.

NCT ID: NCT03595150 Not yet recruiting - Clinical trials for Common Bile Duct Diseases

Diclofenac for Prevention of Post-ERC Pancreatitis

Start date: January 1, 2025
Phase: Phase 2/Phase 3
Study type: Interventional

The study aims at assessing the effectiveness of Diclofenac for prevention of post-ERCP pancreatitis. It will be undertaken embedded in the Swedish national register for Gallstone surgery and ERCP (GallRiks). Patients are randomised to Diclofenac prior to the ERCP or no prophylaxis. GallRiks is used to identify which patients fulfill the eligibility criteria and which patients develop pancreatitis after the ERCP.